News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
184,738 Results
Type
Article (4704)
Company Profile (46)
Press Release (179988)
Multimedia
Podcasts (2)
Webinars (5)
Section
Business (52892)
Career Advice (294)
Deals (10754)
Drug Delivery (19)
Drug Development (8988)
Employer Resources (28)
FDA (5214)
Job Trends (4553)
News (80061)
Policy (6069)
Tag
Academia (601)
Allergies (27)
Alliances (18601)
ALS (18)
Alzheimer's disease (302)
Antibody-drug conjugate (ADC) (14)
Approvals (5251)
Artificial intelligence (160)
Autoimmune disease (4)
Automation (15)
Bankruptcy (67)
Best Places to Work (4211)
BIOSECURE Act (3)
Biosimilars (23)
Biotechnology (33)
Bladder cancer (21)
Brain cancer (5)
Breast cancer (63)
Cancer (482)
Cardiovascular disease (31)
Career advice (260)
Career pathing (9)
CAR-T (20)
Cell therapy (92)
Cervical cancer (5)
Clinical research (7527)
Collaboration (394)
Compensation (62)
Complete response letters (3)
COVID-19 (505)
CRISPR (18)
C-suite (70)
Cystic fibrosis (6)
Data (501)
Decentralized trials (2)
Denatured (2)
Depression (8)
Diabetes (55)
Diagnostics (3124)
Digital health (13)
Diversity (3)
Diversity, equity & inclusion (13)
Drug discovery (37)
Drug pricing (15)
Drug shortages (4)
Duchenne muscular dystrophy (4)
Earnings (17041)
Editorial (3)
Employer resources (26)
Events (23611)
Executive appointments (253)
FDA (5682)
Funding (274)
Gene editing (28)
Generative AI (12)
Gene therapy (67)
GLP-1 (105)
Government (731)
Grass and pollen (1)
Guidances (22)
Healthcare (6101)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (9)
Indications (10)
Infectious disease (541)
Inflammatory bowel disease (26)
Inflation Reduction Act (1)
Influenza (16)
Intellectual property (23)
Interviews (39)
IPO (4351)
IRA (3)
Job creations (517)
Job search strategy (211)
Kidney cancer (1)
Labor market (3)
Layoffs (40)
Leadership (6)
Legal (1051)
Liver cancer (7)
Lung cancer (73)
Lymphoma (24)
Machine learning (3)
Management (13)
Manufacturing (141)
MASH (7)
Medical device (7039)
Medtech (7042)
Mergers & acquisitions (6678)
Metabolic disorders (108)
Multiple sclerosis (12)
NASH (1)
Neurodegenerative disease (16)
Neuropsychiatric disorders (3)
Neuroscience (407)
NextGen: Class of 2025 (2416)
Non-profit (1046)
Now hiring (4)
Obesity (48)
Opinion (41)
Ovarian cancer (13)
Pain (34)
Pancreatic cancer (15)
Parkinson's disease (36)
Partnered (10)
Patents (70)
Patient recruitment (30)
Peanut (16)
People (14141)
Pharmaceutical (12)
Pharmacy benefit managers (3)
Phase I (1792)
Phase II (2865)
Phase III (3302)
Pipeline (291)
Policy (10)
Postmarket research (372)
Preclinical (796)
Press Release (21)
Prostate cancer (23)
Psychedelics (3)
Radiopharmaceuticals (64)
Rare diseases (65)
Real estate (1713)
Recruiting (6)
Regulatory (4786)
Reports (13)
Research institute (627)
Resumes & cover letters (46)
Rett syndrome (3)
RNA editing (1)
RSV (5)
Schizophrenia (8)
Series A (47)
Series B (34)
Service/supplier (7)
Sickle cell disease (8)
Spinal muscular atrophy (15)
Sponsored (16)
Startups (811)
State (1)
Supply chain (33)
Tariffs (1)
Vaccines (115)
Venture capitalists (3)
Weight loss (27)
Women's health (14)
Worklife (4)
Date
Today (26)
Last 7 days (224)
Last 30 days (765)
Last 365 days (9767)
2025 (3299)
2024 (10448)
2023 (11597)
2022 (17446)
2021 (18606)
2020 (18708)
2019 (16612)
2018 (11950)
2017 (9321)
2016 (8691)
2015 (9523)
2014 (6978)
2013 (5946)
2012 (6300)
2011 (6059)
2010 (4859)
Location
Africa (145)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (4)
Asia (9637)
Australia (1136)
California (1619)
Canada (588)
China (134)
Colorado (109)
Connecticut (73)
Delaware (68)
Europe (25040)
Florida (285)
Georgia (105)
Idaho (41)
Illinois (239)
India (10)
Indiana (188)
Iowa (5)
Japan (58)
Kansas (28)
Kentucky (7)
Louisiana (4)
Maine (26)
Maryland (223)
Massachusetts (953)
Michigan (121)
Minnesota (209)
Mississippi (2)
Missouri (47)
Montana (17)
Nebraska (12)
Nevada (21)
New Hampshire (40)
New Jersey (537)
New Mexico (16)
New York (375)
North Carolina (430)
North Dakota (7)
Northern California (659)
Ohio (98)
Oklahoma (6)
Oregon (13)
Pennsylvania (390)
Puerto Rico (3)
Rhode Island (16)
South America (286)
South Carolina (17)
South Dakota (1)
Southern California (581)
Tennessee (40)
Texas (247)
United States (6795)
Utah (56)
Virginia (44)
Washington D.C. (13)
Washington State (114)
West Virginia (2)
Wisconsin (49)
184,738 Results for "pmd solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
PMD Announces New ISIN Code and Timetable for Reverse Split of Shares
PMD Device Solutions In connection with the reverse share split, whereby 128 shares are combined into one new share, PMDS will receive a new ISIN code.
January 29, 2024
·
1 min read
Deals
Promore Pharma AB intends to carry out a reverse acquisition of PMD Device Solutions AB
Promore Pharma AB intends to acquire all the shares in PMD Device Solutions AB by making payment in the form of newly issued shares in the Company.
November 29, 2023
·
12 min read
Press Releases
Phoenix Molecular Designs Dosed First Patient in Dauntless-1, a Phase 2 Clinical Trial of PMD-026 in Combination with Fulvestrant for RSK2-high Breast Cancer
February 21, 2025
·
3 min read
Business
PMD – New Name and Ticker Symbol; Irish Minister To Attend Bell-Ringing Ceremony
Promore Pharma Following the reverse acquisition of Promore Pharma AB and change of name of the company from Promore Pharma AB to PMD Device Solutions AB the Company’s ticker symbol will change from PROMO to PMDS with effect from 17 January 2024.
January 16, 2024
·
2 min read
Deals
PMD Updates on the Reverse Share Split Following the Reverse Acquisition
Device Solutions AB formerly Promore Pharma AB, carried out the reverse acquisition with the PMD group by decision of the extraordinary general meeting on 29 December 2023 and simultaneously decided on a reverse share split.
January 16, 2024
·
2 min read
Update on Reverse Acquisition - PMD Completes Private Placement and Major Shareholder Receives Exemption from Mandatory Bid Requirements
Promore Pharma AB announced on 29 November 2023 the reverse acquisition of PMD Device Solutions AB and PMD’s intended private placement of shares in PMD prior to the Reverse Acquisition.
December 8, 2023
·
5 min read
Press Releases
OMEICOS Therapeutics Completes Enrollment of PMD-OPTION Study in Primary Mitochondrial Disease
September 26, 2024
·
3 min read
Promore Pharma AB (publ) has received approval for continued trading on Nasdaq First North Growth Market and publishes company description
Promore Pharma AB, under name change to PMD Device Solutions AB, has received approval for continued trading on Nasdaq First North Growth Market and publishes a company description prepared in connection with the name and business change of the Company as a result of the planned acquisition of PMD Device Solutions AB.
December 21, 2023
·
2 min read
Report from the Extraordinary General Meeting of Promore Pharma AB Held on 29 December 2023
Promore Pharma Promore Pharma AB, under change of name to PMD Device Solutions AB, held an extraordinary general meeting on Friday, 29 December 2023.
December 29, 2023
·
3 min read
Press Releases
Olympus Demonstrates New AI Endoscopy Solution at DDW®
May 2, 2025
·
5 min read
1 of 18,474
Next
